211 related articles for article (PubMed ID: 30046513)
1. Metformin Treatment Inhibits Motility and Invasion of Glioblastoma Cancer Cells.
Al Hassan M; Fakhoury I; El Masri Z; Ghazale N; Dennaoui R; El Atat O; Kanaan A; El-Sibai M
Anal Cell Pathol (Amst); 2018; 2018():5917470. PubMed ID: 30046513
[TBL] [Abstract][Full Text] [Related]
2. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
[TBL] [Abstract][Full Text] [Related]
3. Swelling-induced chloride current in glioblastoma proliferation, migration, and invasion.
Wong R; Chen W; Zhong X; Rutka JT; Feng ZP; Sun HS
J Cell Physiol; 2018 Jan; 233(1):363-370. PubMed ID: 28262948
[TBL] [Abstract][Full Text] [Related]
4. High-Dose Metformin Plus Temozolomide Shows Increased Anti-tumor Effects in Glioblastoma In Vitro and In Vivo Compared with Monotherapy.
Lee JE; Lim JH; Hong YK; Yang SH
Cancer Res Treat; 2018 Oct; 50(4):1331-1342. PubMed ID: 29334602
[TBL] [Abstract][Full Text] [Related]
5. Fangchinoline suppresses the growth and invasion of human glioblastoma cells by inhibiting the kinase activity of Akt and Akt-mediated signaling cascades.
Guo B; Xie P; Su J; Zhang T; Li X; Liang G
Tumour Biol; 2016 Feb; 37(2):2709-19. PubMed ID: 26408176
[TBL] [Abstract][Full Text] [Related]
6. Metformin treatment reduces temozolomide resistance of glioblastoma cells.
Yang SH; Li S; Lu G; Xue H; Kim DH; Zhu JJ; Liu Y
Oncotarget; 2016 Nov; 7(48):78787-78803. PubMed ID: 27791206
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Mechanism of Adjuvant Treatment of Glioblastoma Using Temozolomide and Metformin.
Feng SW; Chang PC; Chen HY; Hueng DY; Li YF; Huang SM
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897747
[TBL] [Abstract][Full Text] [Related]
8. A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme.
Elmaci İ; Altinoz MA
Biochem Genet; 2016 Oct; 54(5):573-618. PubMed ID: 27377891
[TBL] [Abstract][Full Text] [Related]
9. The Potential Therapeutic Impact of Metformin in Glioblastoma Multiforme.
Sanati M; Aminyavari S; Mollazadeh H; Motamed-Sanaye A; Bibak B; Mohtashami E; Teng Y; Afshari AR; Sahebkar A
Curr Med Chem; 2023; 30(7):857-877. PubMed ID: 35796457
[TBL] [Abstract][Full Text] [Related]
10. Targeting Cancer Cell Metabolism with Metformin, Dichloroacetate and Memantine in Glioblastoma (GBM).
Albayrak G; Konac E; Dere UA; Emmez H
Turk Neurosurg; 2021; 31(2):233-237. PubMed ID: 33372258
[TBL] [Abstract][Full Text] [Related]
11. A Multi-targeted Natural Flavonoid Myricetin Suppresses Lamellipodia and Focal Adhesions Formation and Impedes Glioblastoma Cell Invasiveness and Abnormal Motility.
Zhao HF; Wang G; Wu CP; Zhou XM; Wang J; Chen ZP; To ST; Li WP
CNS Neurol Disord Drug Targets; 2018; 17(7):557-567. PubMed ID: 29886836
[TBL] [Abstract][Full Text] [Related]
12. Advances in Anti-Cancer Drug Development: Metformin as Anti-Angiogenic Supplemental Treatment for Glioblastoma.
Shah S; Mansour HM; Aguilar TM; Lucke-Wold B
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891882
[TBL] [Abstract][Full Text] [Related]
13. A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy.
Ströbele S; Schneider M; Schneele L; Siegelin MD; Nonnenmacher L; Zhou S; Karpel-Massler G; Westhoff MA; Halatsch ME; Debatin KM
PLoS One; 2015; 10(6):e0131670. PubMed ID: 26121251
[TBL] [Abstract][Full Text] [Related]
14. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
[TBL] [Abstract][Full Text] [Related]
15. Demethoxycurcumin Suppresses Proliferation, Migration, and Invasion of Human Brain Glioblastoma Multiforme GBM 8401 Cells
Su RY; Hsueh SC; Chen CY; Hsu MJ; Lu HF; Peng SF; Chen PY; Lien JC; Chen YL; Chueh FS; Chung JG; Yeh MY; Huang YP
Anticancer Res; 2021 Apr; 41(4):1859-1870. PubMed ID: 33813391
[TBL] [Abstract][Full Text] [Related]
16. Thiabendazole Inhibits Glioblastoma Cell Proliferation and Invasion Targeting Mini-chromosome Maintenance Protein 2.
Hu Y; Zhou W; Xue Z; Liu X; Feng Z; Zhang Y; Liu X; Li W; Zhang Q; Chen A; Huang B; Wang J
J Pharmacol Exp Ther; 2022 Jan; 380(1):63-75. PubMed ID: 34750208
[TBL] [Abstract][Full Text] [Related]
17. Multiflorane suppresses the proliferation, migration and invasion of human glioblastoma by targeting MAPK signalling pathway.
Qiu P; Zheng X; Yang H
J BUON; 2020; 25(3):1631-1635. PubMed ID: 32862615
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion.
Chen WL; Barszczyk A; Turlova E; Deurloo M; Liu B; Yang BB; Rutka JT; Feng ZP; Sun HS
Oncotarget; 2015 Jun; 6(18):16321-40. PubMed ID: 25965832
[TBL] [Abstract][Full Text] [Related]
19. 17AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion.
Miekus K; Kijowski J; Sekuła M; Majka M
Oncol Rep; 2012 Nov; 28(5):1903-9. PubMed ID: 22941268
[TBL] [Abstract][Full Text] [Related]
20. Combined treatment with niclosamide and camptothecin enhances anticancer effect in U87 MG human glioblastoma cells.
Valdez L; Cheng B; Gonzalez D; Rodriguez R; Campano P; Tsin A; Fang X
Oncotarget; 2022; 13():642-658. PubMed ID: 35548329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
